Navigation Links
Antidepressants in Pregnancy May Delay Developmental Milestones
Date:2/23/2010

Children exposed in womb slower to sit without support, walk, study finds

TUESDAY, Feb. 23 (HealthDay News) -- Babies of women who take antidepressants during the latter part of pregnancy are slower in reaching some developmental milestones, new research shows.

Using data on more than 81,000 babies born in Denmark, researchers found that children whose mothers took antidepressants during the second or third trimester sat without support later and walked later than children of depressed mothers who did not take medication. This was especially true for boys.

Despite the delays, the children's progress was still well within the bounds of normal development, the researchers noted. Children whose mothers took antidepressants sat about 16 days later and walked nearly a month later than the children of mothers who didn't take the drugs.

According to the paper, researchers said they did not know if the changes were permanent or only temporary.

By 19 months, they found no differences in motor skills between kids exposed and not exposed to antidepressants.

But the 19-month-old children whose mothers had taken antidepressants were less able to occupy themselves for more than 15 minutes than toddlers whose mothers hadn't taken antidepressants.

No other delays in any of the other 14 developmental milestones mothers were asked about, including language development, social development or other motor skills such as head control or rolling from back to belly, were noted among exposed children.

The study is published in the March issue of Pediatrics.

Despite some concerns, Dr. Diane Ashton, deputy medical director of the March of Dimes and an ob-gyn, urged women not to make any hasty decisions about discontinuing the drugs and to consult with their doctors first.

"For the most part, we feel it's important for women to be adequately treated for depression during pregnancy," Ashton said. "Depending on the severity of the symptoms, you may not have a choice. If the mother is depressed or suicidal to the point of hurting herself, she needs treatment."

About 904 women in the study were depressed; of those, 415 women took antidepressants. Most took serotonin reuptake inhibitors (SSRIs), such as fluoxetine (Prozac), sertraline (Zoloft and Lustral), citalopram (Celexa) and paroxetine (Paxil). Some took an older class of drugs, tricyclic antidepressants or other types of antidepressants, including venlafaxine (Effexor). Some took more than one.

While the study isn't the first to show that antidepressants may impact fetal development, it is among the first to look at the child's development after birth, Ashton said.

A 2009 study in the British Medical Journal, also by the Danish researchers, found women who take certain antidepressants during the first three months of pregnancy were at a slightly increased risk of giving birth to babies with septal heart defects, or malformations in the wall separating the right side of the heart from the left. The risks were seen in sertraline and in citalopram.

Other research, however, about the risks of congenital abnormalities has been inconclusive.

So what should women do?

Discontinuing antidepressants is an option, but it has risks, especially if the mother's depression is severe, said David Blackburn, a clinical psychologist and assistant professor of psychiatry and behavioral science at Scott & White Memorial Hospital in Temple, Texas.

Untreated depression may lead women to miss prenatal appointments, eat poorly -- either too much or too little -- and sleep poorly. Some people who are depressed also become socially isolated, or self-medicate with drugs or alcohol. Depression is also a risk for suicide or other self-destructive behaviors.

"Whether women continue with antidepressants has to be decided on an individual basis," Blackburn said. "You have to weigh the risk of the depression with the slight risks of taking the antidepressants."

In the United States, about one in five women have symptoms of depression while pregnant, according to the March of Dimes.

The U.S. Food and Drug Administration and the American College of Obstetricians and Gynecologists (ACOG) have issued warnings about an increased risk of heart defects associated with the use of the Paxil during pregnancy.

Blackburn urged women who don't want to take medications during pregnancy not to try to go it alone and instead consider psychological counseling or support groups.

More information

The March of Dimes has more on depression and pregnancy.



SOURCES: David Blackburn, Ph.D., M.Th., clinical psychologist, Scott & White Memorial Hospital, Temple, Texas, and assistant professor, psychiatry and behavioral science, Texas A&:M Health Science Center; Diane Ashton, M.D., M.P.H., deputy medical director, March of Dimes, White Plains, N.Y.; March 2010 Pediatrics


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Antidepressants After Stroke May Boost Mental Ability
2. Antidepressants May Complicate Breast-Feeding
3. Why Antidepressants Dont Work for Everyone
4. Antidepressants May Raise Womens Stroke Risk
5. Most Antidepressants Miss Key Target of Clinical Depression
6. Antidepressants May Change Your Personality
7. Why antidepressants dont work for so many
8. Antidepressants May Be Linked to Birth Problems
9. Antidepressants Linked to Heart Defects in Newborns
10. Antidepressants: Benefit of SNRI is proven
11. Suicide Risk With Antidepressants Falls With Age
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... On Tuesday, ... hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, ... Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations ...
(Date:4/29/2016)... ... 29, 2016 , ... Dr. Bernie Siegel, (M.D.) ... MEDICINE and MIRACLES") addresses touchy topics related to Death live on Dr. ... Dr. Bernie Siegel, author of a plethora of essential books-to-read for physicians and ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Conditions were ideal ... Cove Island Park on Sunday, with sunny skies, a light breeze and temperatures in ... $33,000. , The 5k Run and Walk and 1-mile walk were held ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... reveals that infants born with severe congenital diaphragmatic hernia have better survival rates ... with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, ...
(Date:4/29/2016)... ... 2016 , ... The Wharton School of the University ... of the 2016 Wharton Business Plan Competition —as well as the Wharton ... the Committee Award for Most ‘Wow Factor,’ making them the first team in ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 New market research ... a report that provides an overview of the ... by identifying new targets and MOAs to produce ... discussed in this H1 2016 Osteoarthritis Pipeline report ... Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
(Date:4/27/2016)... Shire plc (LSE: SHP, NASDAQ: ... Financial Officer, will present at the Deutsche Bank 41st Annual ... on Wednesday, May 04, 2016, 10:00 am EDT (15:00 BST). ... the Presentations and Webcasts section of Shire,s Investor website at ... be available on this same website for approximately 90 days. ...
Breaking Medicine Technology: